Abstract
Omeprazole (OME) exhibits low stability to light, heat and humidity. In stress conditions OME stability should improve under inclusion complex form with hydroxypropyl-β-cyclodextrin (HPβCD). Stability of OME, its physical mixture (PM) with HPβCD and OME:HPβCD inclusion complex was assessed during 60 days. The inclusion complexes were prepared by kneading and freeze-drying techniques and characterized by differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR). A molecular modelling was also held to predict the most probable tridimensional conformation of inclusion complex OME:HPβCD. The inhibitory activity of free and complexed OME on selected enzymes, namely, papain (protease model of the proton pump) and acetylcholinesterase (enzyme present in cholinergic neurons and also involved in Alzheimer’s disease) was compared. The results obtained show that HPβCD do not protect against OME degradation, in any prepared powder, in the presence of light, heat and humidity. This may indicate that the reactive group of OME is not included in the HPβCD cavity. This fact is supported by molecular modelling data, which demonstrated that 2-pyridylmethyl group of OME is not included into the cyclodextrin cavity. In relation to enzymatic assays it was observed that free OME and OME in the binary systems showed identical inhibitory activity on papain and acethylcolinesterase, concluding that HPβCD do not affect OME activity on these two enzymes.
Similar content being viewed by others
References
Aihara, T., Nakamura, E., Amagase, K., Tomita, K., Fujishita, T., Furutani, K., Okabe, S.: Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol. Ther. 98(1), 109–127 (2003)
Ruiz, M., Reyes, I., Parera, A., Allardo, V.: Determination of the stability of omeprazole by means of differential scanning calorimetry. J. Therm. Anal. 51, 29–35 (1998)
Storpirtis, S., Rodrigues, D.: In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets. Drug Dev. Ind. Pharm. 24(11), 1101–1107 (1998)
Arias, M., Moyano, J., Muñoz, P., Ginés, J., Justo, A., Giordano, F.: Study of Omeprazole-γ-cyclodextrin complexation in the solid state. Drug Dev. Ind. Pharm. 26(3), 253–259 (2000)
Brewster, M., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007)
Hedges, A.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035–2044 (1998)
Marques, H.: Cyclodextrins’ derivatives. Absorption, toxicity metabolism and fate. Rev. Port. Farm. 44(4), 147–156 (1994)
Irie, T., Uekama, K.: Pharmaceutical applications of cyclodextrins III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86(2), 147–162 (1997)
Loftsson, T., Hreinsdóttir, D., Másson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302(1–2), 18–28 (2005)
Salas, C., Goes, M., Hernandez, M., Lopes, M.: Plant cysteine proteinases: evaluation of the pharmacological activity. Phytochemistry 69, 2263–2269 (2008)
Ahmed, M., Rocha, J., Mazzanti, C., Morsch, A., Cargnelutti, D., Corrêa, M., Loro, V., Morsch, V., Schetinger, M.: Malathion, carbofuran and paraquat inhibit Bungarus sindanus (krait) venom acetylcholinesterase and human serum butyrylcholinesterase in vitro. Ecotoxicology 16, 363–369 (2007)
Abou-Donia, M.: Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 58(8), 484–497 (2003)
Ibach, B., Haen, E.: Acetylcholinesterase inhibition in Alzheimer’s disease. Curr. Pharm. Des. 10, 231–251 (2004)
Cheng, F., Ho, Y., Hung, L., Chen, C., Tsai, T.: Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. J. Chromatogr. A 949, 35–42 (2002)
Dewar, M., Zoebisch, E., Healy, E.: AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902–3909 (1985)
Zhao, G., Zhou, Z.: Vinyl sulfonium as novel proteolytic enzyme inhibitor. Bioorg. Med. Chem. Lett. 11, 2331–2335 (2001)
Falé, P., Borges, C., Madeira, P., Ascensão, L., Araújo, M., Florêncio, M., Serralheiro, M.: Rosmarinic acid, scutellarein 4′-methyl ether 7-O-glucuronide and (16S)-coleon E are the main compounds responsible for the acetylcholinesterase and antioxidant activity in herbal tea of Plectranthus barbatus (“falso boldo”). Food Chem. 114(3), 798–805 (2009)
Mura, P., Adragna, E., Rabasco, A., Moyano, J., Pérez-Martìnez, J., Arias, M., Ginés, J.: Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev. Ind. Pharm. 25(3), 279–287 (1999)
Hirlekar, R., Kadam, V.: Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 63, 219–224 (2009)
Aleem, O., Kuchekar, B., Pore, Y., Late, S.: Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J Pharm. Biomed. Anal. 47(3), 535–540 (2008)
Loftsson, T., Brewster, M.: Pharmaceutical applications of cyclodextrins. 1 Drug solubilization and stabilization. J. Pharm. Sci. 85(10), 1017–1025 (1996)
Gubica, T., Winnicka, E., Temeriusz, A., Kańska, M.: The influence of selected O-alkyl derivatives of cyclodextrins on the enzymatic decomposition of l-tryptophan by l-tryptophan indole-lyase. Carbohydr. Res. 344(3), 304–310 (2009)
López, S., Bastida, J., Viladomat, F., Codina, C.: Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci. 71, 2521–2529 (2002)
Marco, L., Carreiras, M.: Galanthamine, a natural product for the treatment of Alzheimer’s disease. Recent Pat. CNS Drug Discov. 1, 105–111 (2006)
Houghton, P., Ren, Y., Howes, M.: Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. 23, 181–199 (2006)
Acknowledgments
The authors would like to thank Laboratórios Medinfar for the kind donation of Omeprazole and Doctor R. Guedes for the help with the molecular simulation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramos, M., Salústio, P., Serralheiro, L. et al. Stability and enzymatic studies with omeprazole:hydroxypropyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem 70, 407–414 (2011). https://doi.org/10.1007/s10847-010-9884-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9884-3